CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- Open-market buys, last 90 days
- $21,250
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$21,250. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-08 | GORDON CARL L Director | Purchase | +402,000 | $3.21 | $1.3M | 15,219,994 |
| 2022-09-28 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | $2.32 | $23K | 5,431,873 |
| 2022-09-26 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $2.27 | $34K | 5,421,873 |
| 2022-09-07 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $3.03 | $45K | 5,406,873 |
| 2022-09-01 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $2.83 | $42K | 5,391,873 |
| 2022-08-17 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $3.05 | $46K | 5,376,873 |
| 2022-08-10 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $2.64 | $40K | 5,361,873 |
| 2022-08-01 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $2.58 | $39K | 5,346,873 |
| 2022-06-21 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $2.80 | $56K | 5,331,873 |
| 2022-06-16 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $2.34 | $47K | 5,311,873 |
| 2022-06-13 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +30,000 | $2.29 | $69K | 5,291,873 |
| 2022-06-06 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +30,000 | $2.83 | $85K | 5,261,873 |
| 2022-06-01 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $3.03 | $61K | 5,231,873 |
| 2022-05-26 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $3.04 | $61K | 5,211,873 |
| 2022-05-23 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +18,355 | $2.72 | $50K | 5,191,873 |
| 2022-05-17 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,215 | $2.47 | $50K | 5,173,518 |
| 2022-05-13 | GORDON CARL L Director | Purchase | +30,722 | $2.49 | $76K | 14,817,994 |
| 2022-05-13 | ORBIMED ADVISORS LLC Director | Purchase | +30,722 | $2.49 | $76K | 14,817,994 |
| 2022-05-12 | GORDON CARL L Director | Purchase | +97,094 | $2.35 | $228K | 14,787,272 |
| 2022-05-12 | ORBIMED ADVISORS LLC Director | Purchase | +97,094 | $2.35 | $228K | 14,787,272 |
Page 5 of 8 · 143 trades